Interleukin-23 serum levels in patients affected by peripheral arterial disease

Clinical Biochemistry

Volumn 45, Issue 3, 2012, Pages 275-278

  David, Antonio ^a   Saitta, Salvatore ^a   De Caridi, Giovanni ^a   Benedetto, Filippo ^a   Massara, Mafalda ^a   Risitano, Domenica Claudia ^a   Venuti, Francesco Saverio ^a   Spinelli, Francesco ^a   Gangemi, Sebastiano ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b CNR   (Italy)

Author keywords

Cytokines; Inflammation; Interleukin 23 (IL 23); Lymphocyte T helper 17 (Th 17); Peripheral arterial disease (PAD)

Indexed keywords

C REACTIVE PROTEIN; CREATININE; FIBRINOGEN; INTERLEUKIN 23;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ERYTHROCYTE COUNT; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; LEG DISEASE; LEUKOCYTE COUNT; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERLEUKIN-23 SUBUNIT P19; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE;

EID: 84856420693     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.12.010     Document Type: Article

References (10)

1. Jelnes R., Gaardsting O., Hougaard Jensen K., Baekgaard N., Tonnesen K.H., Schroeder T. Fate in intermittent claudication: outcome and risk factors. Br Med J (Clin Res Ed) 1986, 293:1137-1140.
2. A.T. Hirsch, Z.J. Haskal, N.R. Hertzer, C.W. Bakal, M.A. Creager, J.L. Halperin, L.F. Hiratzka, W.R. Murphy, J.W. Olin, J.B. Puschett, K.A. Rosenfield, D. Sacks, J.C. Stanley, LM Jr Taylor, C.J. White, J. White, R.A. White, E.M. Antman, S.C. Jr Smith, C.D. Adams, J.L. Anderson, D.P. Faxon, V. Fuster, R.J. Gibbons, S.A. Hunt, A.K. Jacobs, R. Nishimura, J.P. Ornato, R.L. Page, B. Riegel; American Association for Vascular Surgery; Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease; American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; Vascular Disease Foundation. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006;113:463-654.
3. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998, 97:425-428.
4. Piccotti J.R., Li K., Chan S.Y., Ferrante J., Magram J., Eichwald E.J., et al. Alloantigen-reactive Th1 development in IL-12-deficient mice. J Immunol 1998, 160:1132-1138.
5. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240.
6. Tato C.M., Cua D.J. Reconciling id, ego, and superego within interleukin-23. Immunol Rev 2008, 226:103-111.
7. Szmitko P.E., Wang C.H., Weisel R.D. New markers of inflammation and endothelial cell activation: part I. Circulation 2003, 108:1917-1923.
8. Baba T., Uchimura I., Fujisawa K., Morohoshi M., Asaoka H., Tanaka A., et al. Production of interleukin-6 induced by hypoxia linked to peripheral arterial disease. Ann N Y Acad Sci 1997, 15:542-548.
9. Testa M., De Ruvo E., Russo A., Citterio F., Serino F., Mangoni A., et al. Induction of interleukin-1beta and interleukin-6 gene expression in hypoperfused skeletal muscle of patients with peripheral arterial disease. Ital Heart J 2000, 1:64-67.
10. Konoeda F., Shichita T., Yoshida H., Sugiyama Y., Muto G., Hasegawa E., et al. Therapeutic effect of IL-12/23 and their signaling pathway blockade on brain ischemia model. Biochem Biophys Res Commun 2010, 402:500-506.